| 100346-6 | Clotting time (Blood, thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited) |
| 100347-4 | Clot formation (Blood, thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibited) |
| 100429-0 | LRBA deficiency panel - Blood |
| 100430-8 | Cells.LRBA+/Cells.CD3+CD14-CD45+ (Blood, flow cytometry (fc)) |
| 100431-6 | Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity (Blood, flow cytometry (fc)) |
| 100432-4 | Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ (Blood, flow cytometry (fc)) |
| 100433-2 | Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity (Blood, flow cytometry (fc)) |
| 100663-4 | TPMT gene c.460G>A and c.719A>G (Blood, qualitative, molecular genetics method) |
| 100664-2 | NUDT15 gene c.50_55dup and c.415C>T (Blood, qualitative, molecular genetics method) |
| 100665-9 | NUDT15 gene c.415C>T (Blood, qualitative, molecular genetics method) |
| 100666-7 | NUDT15 gene c.416G>A (Blood, qualitative, molecular genetics method) |
| 100667-5 | NUDT15 gene c.52G>A (Blood, qualitative, molecular genetics method) |
| 100668-3 | NUDT15 gene c.50_55dup (Blood, qualitative, molecular genetics method) |
| 100669-1 | NUDT15 gene c.50_55del (Blood, qualitative, molecular genetics method) |
| 100671-7 | Aspergillus sp DNA (Blood, qualitative, naa with probe detection) |
| 100672-5 | Aspergillus fumigatus DNA (Blood, qualitative, naa with probe detection) |
| 100673-3 | Aspergillus terreus DNA (Blood, qualitative, naa with probe detection) |
| 100674-1 | BK virus DNA (viral load) (Blood, naa with probe detection) |
| 100675-8 | Cytomegalovirus DNA (viral load) (Blood, naa with probe detection) |
| 100676-6 | Cytomegalovirus DNA (viral load) (Blood, naa with probe detection) |
| 100678-2 | Epstein Barr virus DNA (viral load) (Blood, naa with probe detection) |
| 100680-8 | Herpes virus 6 DNA (viral load) (Blood, naa with probe detection) |
| 100682-4 | Herpes virus 7 DNA (viral load) (Blood, naa with probe detection) |
| 100684-0 | Herpes virus 8 DNA (viral load) (Blood, naa with probe detection) |
| 100688-1 | Parvovirus B19 DNA (viral load) (Blood, naa with probe detection) |
| 100691-5 | Varicella zoster virus DNA (viral load) (Blood, naa with probe detection) |
| 100762-4 | HBA2 gene.c.377T>C (Blood, qualitative, molecular genetics method) |
| 100858-0 | Cells.CD4+CD154+/CD4 cells --after stimulation with SARS-CoV-2 Spike peptide (Blood) |
| 100859-8 | Cells.CD4.Interferon gamma-expressing/CD4 cells --after stimulation with SARS-CoV-2 Spike peptide (Blood) |
| 100860-6 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells --after stimulation with SARS-CoV-2 Spike peptide (Blood) |
| 100861-4 | Cells.CD4+CD154+/CD4 cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) |
| 100862-2 | Cells.CD4.Interferon gamma-expressing/CD4 cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) |
| 100863-0 | Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) |
| 100994-3 | B-cell CD19 and CD20 subsets panel - Blood (flow cytometry (fc)) |
| 101117-0 | Sezary syndrome monitoring Document (Blood, flow cytometry (fc)) |
| 101118-8 | Sezary syndrome diagnosis Document (Blood, flow cytometry (fc)) |
| 101120-4 | Candida glabrata+krusei DNA (Blood, qualitative, naa with probe detection) |
| 101121-2 | Candida albicans and tropicalis DNA (Blood, qualitative, naa with probe detection) |
| 101122-0 | Mephobarbital (Blood, confirmatory method) |
| 101146-9 | Monocyte subsets panel - Blood (flow cytometry (fc)) |
| 101147-7 | Monocytes/Leukocytes (Blood, flow cytometry (fc)) |
| 101148-5 | CD14+CD16- (Classical) Monocytes/Monocytes (Blood) |
| 101255-8 | Herpes virus 6 DNA (viral load) (Blood, naa with probe detection) |
| 101302-8 | Leptospira sp DNA (Blood, qualitative, naa with non-probe detection) |
| 101303-6 | Chikungunya virus RNA (Blood, qualitative, naa with non-probe detection) |
| 101304-4 | Dengue virus 1+2+3+4 RNA (Blood, qualitative, naa with non-probe detection) |
| 101305-1 | Plasmodium sp DNA (Blood, qualitative, naa with non-probe detection) |
| 101306-9 | Plasmodium falciparum DNA (Blood, qualitative, naa with non-probe detection) |
| 101307-7 | Plasmodium vivax+ovale DNA (Blood, qualitative, naa with non-probe detection) |
| 101341-6 | BK virus DNA (viral load) (Blood, naa with probe detection) |
| 101343-2 | Erythrocytes.parasite sp infected/cells (Blood) |
| 101344-0 | Acute febrile illness global pathogens panel - Blood (naa with non-probe detection) |
| 101360-6 | Bacillus anthracis plasmid pXO1 DNA (Blood, qualitative, naa with non-probe detection) |
| 101361-4 | Bacillus anthracis plasmid pXO2 DNA (Blood, qualitative, naa with non-probe detection) |
| 101362-2 | Bacillus anthracis DNA (Blood, qualitative, naa with non-probe detection) |
| 101363-0 | Yersinia pestis DNA (Blood, qualitative, naa with non-probe detection) |
| 101364-8 | Francisella tularensis DNA (Blood, qualitative, naa with non-probe detection) |
| 101365-5 | Coxiella burnetii DNA (Blood, qualitative, naa with non-probe detection) |
| 101366-3 | Ebola virus RNA (Blood, qualitative, naa with non-probe detection) |
| 101367-1 | Marburg virus RNA (Blood, qualitative, naa with non-probe detection) |
| 101376-2 | Megakaryocytes (qualitative, light microscopy) |
| 101406-7 | Sudan virus RNA (Blood, qualitative, naa with probe detection) |
| 101414-1 | Lymphocyte TCR alpha beta double negative subsets panel - Blood |
| 101469-5 | HBA1+2 gene FIL deletion (Blood, qualitative, molecular genetics method) |
| 101470-3 | HBA1+2 gene THAI deletion (Blood, qualitative, molecular genetics method) |
| 101471-1 | Alpha globin gene deletion panel - Blood |
| 101506-4 | Phosphatidylethanol panel - Blood |
| 101538-7 | SMA residual risk (Blood, molecular genetics method narrative) |
| 101545-2 | FCGR3A gene.p.Phe158 (Blood, molecular genetics method nominal) |
| 101546-0 | FCGR3A gene.p.Val158 (Blood, molecular genetics method nominal) |
| 101643-5 | CD3 cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) |
| 101644-3 | CD3+CD4+ (T4 helper) cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) |
| 101645-0 | CD3+CD8+ (T8 suppressor) cells --after stimulation with SARS-CoV-2 Nucleocapsid peptide (Blood) |
| 101655-9 | Basic metabolic and hematocrit panel - Blood |
| 101748-2 | Maraviroc anticipated activity Qualitative (Blood, qualitative, rt-pcr) |
| 101749-0 | Borrelia miyamotoi DNA (Blood, qualitative, naa with probe detection) |
| 101751-6 | Lithium (Blood, inductively coupled plasma/optical emission spectrometry (icp/oes)) |
| 101981-9 | Maximum clot strength amplitude (Blood, thromboelastography.resonance.kaolin induced) |
| 101996-7 | Erythrocytes.Plasmodium falciparum infected/Erythrocytes (Blood, microscopy) |
| 101997-5 | Clot initiation.kaolin induced (Blood, thromboelastography) |
| 101998-3 | Clot formation.kaolin induced (Blood, thromboelastography) |
| 102000-7 | Maximum clot strength amplitude (Blood, thromboelastography.kaolin induced) |
| 102001-5 | Clot initiation.kaolin induced (Blood, thromboelastography^after addition of heparinase) |
| 102002-3 | Clot formation.kaolin induced (Blood, thromboelastography^after addition of heparinase) |
| 102003-1 | Reduction in kaolin induced clot strength (Blood, thromboelastography ^30 min p max clot amplitude + heparinase) |
| 102004-9 | Clot angle.kaolin induced (Blood, thromboelastography^after addition of heparinase) |
| 103142-6 | Cell-free DNA.donor/Cell-free DNA.total (Blood, sequencing --post transplant) |
| 103156-6 | CD3 cells recipient derived/Cells.CD3 (Blood, molecular genetics method --post bone marrow transplant) |
| 103158-2 | Cells.CD15.recipient derived/Cells.CD15 --post bone marrow transplant (Blood) |
| 103160-8 | Cells.CD33.recipient derived/Cells.CD33 --post bone marrow transplant (Blood) |
| 10331-7 | Rh (Blood) |
| 1034-8 | Fetal cell screen (Blood) |
| 10346-5 | Hemoglobin A (electrophoresis) |
| 10347-3 | Babesia microti identified (Blood, light microscopy) |
| 103556-7 | PLA2G7 and PLAC8 gene expression level (Blood, molecular genetics method) |
| 103617-7 | Helicobacter pylori IgG Ab (Blood, qualitative, immunoassay) |
| 103665-6 | CD4+ CD26- Cells/CD4 cells (Blood, flow cytometry (fc)) |
| 103681-3 | CD19 cells/Lymphocytes (Blood) |
| 10371-3 | Bite cells (qualitative, light microscopy) |
| 103716-7 | Yersinia pestis DNA (Blood, qualitative, naa with non-probe detection) |